BioDelivery Sciences Profit Margin 2006-2021 | BDSI
Current and historical gross margin, operating margin and net profit margin for BioDelivery Sciences (BDSI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. BioDelivery Sciences net profit margin as of June 30, 2021 is 20.65%.
|BioDelivery Sciences Annual Profit Margins
|BioDelivery Sciences Quarterly Profit Margins
||Medical - Biomedical and Genetics
BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any process, substance, or combination thereof, that delivers drugs into the body.